ATE454889T1 - Arzneimittel zur behandlung von sarkoglykanopathien - Google Patents

Arzneimittel zur behandlung von sarkoglykanopathien

Info

Publication number
ATE454889T1
ATE454889T1 AT07803872T AT07803872T ATE454889T1 AT E454889 T1 ATE454889 T1 AT E454889T1 AT 07803872 T AT07803872 T AT 07803872T AT 07803872 T AT07803872 T AT 07803872T AT E454889 T1 ATE454889 T1 AT E454889T1
Authority
AT
Austria
Prior art keywords
sarcoglycanopathies
treatment
medicinal products
inhibitors
erad
Prior art date
Application number
AT07803872T
Other languages
English (en)
Inventor
Isabelle Richard
Original Assignee
Genethon
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genethon, Centre Nat Rech Scient filed Critical Genethon
Application granted granted Critical
Publication of ATE454889T1 publication Critical patent/ATE454889T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT07803872T 2006-07-18 2007-07-16 Arzneimittel zur behandlung von sarkoglykanopathien ATE454889T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0653020A FR2903905B1 (fr) 2006-07-18 2006-07-18 Medicaments pour le traitement des sarcoglycanopathies
PCT/FR2007/001211 WO2008009802A2 (fr) 2006-07-18 2007-07-16 Medicaments comprenant un inhibiteur des alpha-mannosidases de classe i pour le traitement des sarcoglycanopathies

Publications (1)

Publication Number Publication Date
ATE454889T1 true ATE454889T1 (de) 2010-01-15

Family

ID=37663139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07803872T ATE454889T1 (de) 2006-07-18 2007-07-16 Arzneimittel zur behandlung von sarkoglykanopathien

Country Status (10)

Country Link
US (2) US8273763B2 (de)
EP (1) EP2063877B1 (de)
JP (1) JP5296678B2 (de)
AT (1) ATE454889T1 (de)
CA (1) CA2658400C (de)
DE (1) DE602007004348D1 (de)
ES (1) ES2335623T3 (de)
FR (1) FR2903905B1 (de)
PT (1) PT2063877E (de)
WO (1) WO2008009802A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2993461B1 (fr) * 2012-07-19 2014-08-08 Genethon Utilisation de composes modifiant l'epigenome pour le traitement des maladies genetiques musculaires liees a une anomalie de conformation proteique
ITMI20122065A1 (it) * 2012-12-03 2014-06-04 Univ Padova Uso dei correttori del cftr nel trattamento delle patologie del muscolo striato
US11298348B2 (en) * 2018-01-11 2022-04-12 Inserm (Institut National De La Sante Et De La Recherche Médicale) Combination treatment of sarcoglycanopathies
EP3685846A1 (de) 2019-01-24 2020-07-29 Genethon Verwendung von thiostrepton oder dessen derivaten zur behandlung von genetischen erkrankungen im zusammenhang mit einer proteinfehlfaltungserkrankung
EP4081220A1 (de) 2019-12-26 2022-11-02 Centre d'Etude des Cellules Souches (CECS) Kombination eines proteasom-inhibitors und eines hdac-inhibitors und seine verwendung zur behandlung von genetischen erkrankungen, die mit einer protein-konformationsstörung verbunden sind

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012968A1 (fr) * 1991-01-28 1992-08-06 Nippon Shinyaku Co., Ltd. Composition pharmaceutique contre les thrombis
EP1618881A1 (de) * 2004-07-20 2006-01-25 Santhera Pharmaceuticals (Schweiz) GmbH Verwendung von steroiden ohne glucocorticoid aktivität zur behandlung von muskulärer dystrophie
CA2577987A1 (en) * 2004-08-25 2006-03-02 Santhera Pharmaceuticals (Schweiz) Ag Alpha-keto carbonyl calpain inhibitors
JP2008510759A (ja) * 2004-08-25 2008-04-10 サンセラ ファーマシューティカルズ （シュバイツ） アーゲー α−ケトカルボニルカルパイン阻害剤

Also Published As

Publication number Publication date
CA2658400C (fr) 2015-02-10
FR2903905A1 (fr) 2008-01-25
WO2008009802A3 (fr) 2008-05-29
FR2903905B1 (fr) 2009-03-06
CA2658400A1 (fr) 2008-01-24
JP2009543854A (ja) 2009-12-10
ES2335623T3 (es) 2010-03-30
WO2008009802A2 (fr) 2008-01-24
US20100010036A1 (en) 2010-01-14
US8273763B2 (en) 2012-09-25
DE602007004348D1 (de) 2010-03-04
PT2063877E (pt) 2010-02-09
US8673935B2 (en) 2014-03-18
EP2063877B1 (de) 2010-01-13
JP5296678B2 (ja) 2013-09-25
US20130035353A1 (en) 2013-02-07
EP2063877A2 (de) 2009-06-03

Similar Documents

Publication Publication Date Title
GEP20146060B (en) Pyridyl inhibitors of hedgehog signalling
EP4371560A3 (de) Pharmazeutische zusammensetzung, pharmazeutische darreichungsform, verfahren zu ihrer herstellung, verfahren zur behandlung und verwendungen davon
UA89220C2 (ru) Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы
MA32200B1 (fr) Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation
MX2011012122A (es) Derivados de tiofeno.
TW201712023A (en) Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
MY148534A (en) Inhibitors of human immunodeficiency virus replication
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
UA110199C2 (xx) Тверда дисперсія рифаксиміну
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
MX2009006170A (es) Compuestos y composiciones como inhibidores de cinasa.
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
WO2008064345A3 (en) Microorganism killing compounds
WO2009130422A3 (fr) N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog
GEP20135832B (en) Benzothiazines derivatives, preparation thereof, and their application as drugs
ATE454889T1 (de) Arzneimittel zur behandlung von sarkoglykanopathien
MX2010002506A (es) Compuestos de nicotinamida sustituidos y uso de estos en medicamentos.
AU2010323104A8 (en) Sialochimeric compounds
IL191670A0 (en) Compounds for the inhibition of apoptosis
MX2013002503A (es) Combinacion de inhibidores de hdac con farmacos para trombocitopenia.
MY142817A (en) New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties